India bans exports of anti-viral drug Remdesivir as Covid-19 cases surge
Coronavirus chronicle
11 April, 2021, 06:15 pm
Last modified: 11 April, 2021, 06:20 pm
Seven Indian companies have licensed the drug from Gilead Sciences, with an installed capacity of about 3.9 million units per month
Photo: Collected
India said on Sunday it had banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients after a record spike in Covid-19 cases sent demand surging.
"In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves," the health ministry said in a statement.
Seven Indian companies have licensed the drug from Gilead Sciences, with an installed capacity of about 3.9 million units per month.
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.